Page last updated: 2024-10-25

clofibrate and Coronary Artery Disease

clofibrate has been researched along with Coronary Artery Disease in 7 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research Excerpts

ExcerptRelevanceReference
"Therefore clinicians treating coronary artery disease need to emphasize secondary prevention and recognize the key role of cholesterol-lowering therapy."2.40[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy]. ( Herzum, M; Maisch, B; Schaefer, JR, 1999)
"Clofibrate treatment significantly reduced the content of esterified cholesterol in this vessel."1.27Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs. ( Jacobsson, L, 1987)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Immich, H1
Pritzker, LB1
Schaefer, JR1
Herzum, M1
Maisch, B1
Kinoshita, M1
Klungel, OH1
Heckbert, SR1
de Boer, A1
Leufkens, HG1
Sullivan, SD1
Fishman, PA1
Veenstra, DL1
Psaty, BM1
Oikawa, S1
Jacobsson, L1

Reviews

3 reviews available for clofibrate and Coronary Artery Disease

ArticleYear
Do lipid lowering drugs reduce the risk of coronary heart disease?
    Critical reviews in clinical laboratory sciences, 1998, Volume: 35, Issue:6

    Topics: Angiography; Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Artery Disease

1998
[Prevention of coronary heart disease--"evidence-based medicine" of antilipemic therapy].
    Herz, 1999, Volume: 24, Issue:1

    Topics: Anticholesteremic Agents; Clinical Trials as Topic; Clofibrate; Coronary Artery Disease; Evidence-Ba

1999
[Fibric acid derivatives].
    Nihon rinsho. Japanese journal of clinical medicine, 1999, Volume: 57, Issue:12

    Topics: Anticholesteremic Agents; Clofibrate; Coronary Artery Disease; Humans; Hypolipidemic Agents

1999

Other Studies

4 other studies available for clofibrate and Coronary Artery Disease

ArticleYear
[Cholesterol and coronary sclerosis].
    Versicherungsmedizin, 1997, Jun-01, Volume: 49, Issue:3

    Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Artery Disease; Humans; Hypercholesterol

1997
Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    The Annals of pharmacotherapy, 2002, Volume: 36, Issue:5

    Topics: Cholesterol; Clofibrate; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Humans;

2002
[Endogenous hypertriglyceridemia].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1992, Nov-10, Volume: 81, Issue:11

    Topics: Clofibrate; Coronary Artery Disease; Diet; Exercise Therapy; Female; Humans; Hyperlipoproteinemia Ty

1992
Influence of clofibrate on the plasma lipoprotein pattern and on the lipid content and protein and collagen synthesis in atherosclerotic coronary arteries and abdominal aorta from hypercholesterolemic mini-pigs.
    Atherosclerosis, 1987, Volume: 63, Issue:2-3

    Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Clofibrate; Collagen; Coronary Artery Disease; Coronary

1987